NEW YORK, Feb. 24, 2011 /PRNewswire/ -- Get content from Lundbeck at:
Full year revenue was DKK 14,765 million and increased 7% compared to 2009, driven by a positive development in all regions. Profit from operations (EBIT) was DKK 3,357 million, increasing 17% and corresponding to an EBIT margin of 22.7% for the year. Products Cipralex®, Ebixa® and Azilect® continue to show strong growth of 9%, 11% and 34% respectively. Lexapro® revenue was marginally down compared to 2009 and Xenazine® contributed DKK 610 million growing 105% compared to last year. Available video includes headquarter shots.
thenewsmarket.com delivers free broadcast- and streaming-quality video and multimedia content directly to media around the world, 24/7. More than 25,000 media outlets in 190+ countries use thenewsmarket.com, including the AP, BBC, CNBC, CNN, France 24, N24, nytimes.com, RAI, TVE, ZDF and a lot more.
Registered journalists can preview and download video, audio, text, graphics and photos at http://www.thenewsmarket.com.
If not already registered, please take a moment to sign up - registration is quick, easy and free: http://www.thenewsmarket.com/registration
We are always happy to receive your feedback, suggestions or enquiries. Email us at firstname.lastname@example.org
Story Id: 21810
Copyright©2010 PR Newswire.
All rights reserved